Results 71 to 80 of about 4,259,087 (330)
Dysregulated protein modifications drive tumorigenesis. RINES, an E3 ubiquitin ligase, represses tumor cell proliferation and metastasis by facilitating RING domain‐dependent, ubiquitin–proteasome‐mediated degradation of STAT3 and MYC, which consequently restrains cancer stemness and oncogenic progression.
Lili Li +8 more
wiley +1 more source
Friedreich’s ataxia (FRDA) is caused by transcriptional repression of the nuclear FXN gene encoding the essential mitochondrial protein frataxin. Based on the hypothesis that the acetylation state of the histone proteins is responsible for gene silencing
Joel M. Gottesfeld +4 more
doaj +1 more source
Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
Despite recent advances in multimodality therapy for glioblastoma (GB) incorporating surgery, radiotherapy, chemotherapy and targeted therapy, the overall prognosis remains poor.
Liesbeth Everix +4 more
doaj +1 more source
GSLHC finds novel HDAC inhibitors.
The three know HDAC inhibitors valproic acid, trichostatin A, and vorinostat, are all significantly enriched by 597 tags with permutation p< 0.005; these 597 tags were used in a new heatmap in the GSLHC protocol.
Zhen-Hua Jin (814844) +5 more
core +1 more source
HR23B, a biomarker for HDAC inhibitors [PDF]
As our understanding of cancer biology increases and novel therapies are developed, an increasing number of predictive biomarkers are becoming clinically available.
core +1 more source
Cutaneous T-cell lymphomas (CTCLs) are a subset of T-cell malignancies presenting in the skin. The treatment options for CTCL, in particular in advanced stages, are limited.
Muddassir Malik (14072394) +7 more
core +1 more source
A novel PLGA/PBAE polymer microparticle platform revolutionizes intermediate‐stage liver cancer treatment by co‐delivering panobinostat and IL‐12 via a single TACE‐like injection. This sustained‐release system overcomes tumor immunosuppression, triggers robust innate and adaptive immune responses, and establishes tertiary lymphoid structures ...
Hongzhe Yu +7 more
wiley +1 more source
Acquired vorinostat resistance shows partial cross-resistance to "second-generation" HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities [PDF]
Histonedeacetylase(HDAC)inhibitors such as vorinostat (suberoylanilide hydroxamicacid), valproicacid,romidepsin (FK-228), and LBH589 comprise a relatively new class of potentanti canceragents.
Dedes, J
core +2 more sources
Inherited retinal degeneration (IRD) represents a diverse group of gene mutation-induced blinding diseases. In IRD, the loss of photoreceptors is often connected to excessive activation of histone-deacetylase (HDAC), poly-ADP-ribose-polymerase (PARP ...
Yujie Dong +6 more
doaj +1 more source
HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases [PDF]
Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail, chromatin conformation, protein-DNA interaction, and even transcription. HDACs are also post-transcriptional modifiers that regulate the protein acetylation implicated in several pathophysiologic states.
Yoon, Somy, Eom, Gwang Hyeon
openaire +2 more sources

